Unique ID issued by UMIN | UMIN000006051 |
---|---|
Receipt number | R000007159 |
Scientific Title | A randomized, parallel-group, double-blind study of high-frequency, repetitive transcranial magnetic stimulation (rTMS) for schizophrenic patients with auditory hallucinations. |
Date of disclosure of the study information | 2011/07/30 |
Last modified on | 2017/12/19 20:16:12 |
A randomized, parallel-group, double-blind study of high-frequency, repetitive transcranial magnetic stimulation (rTMS) for schizophrenic patients with auditory hallucinations.
A randomized, parallel-group, double-blind study of repetitive transcranial magnetic stimulation (rTMS) for schizophrenic patients with auditory hallucinations.
A randomized, parallel-group, double-blind study of high-frequency, repetitive transcranial magnetic stimulation (rTMS) for schizophrenic patients with auditory hallucinations.
A randomized, parallel-group, double-blind study of repetitive transcranial magnetic stimulation (rTMS) for schizophrenic patients with auditory hallucinations.
Japan |
Schizophrenia, Schizoaffective disorder
Psychiatry |
Others
NO
Examination of effectiveness of high-frequency rTMS for auditory hallucinations.
Efficacy
Confirmatory
Explanatory
Not applicable
Auditory Hallucination Rating Scale
Positive and Negative Syndrome Scale, Brief Psychiatric Rating Scale
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
Central registration
2
Treatment
Device,equipment |
Two-day (two times in the morning and in the evening per day), 20Hz active rTMS procedure and one-month observation period
Two-day (two times in the morning and in the evening per day), sham procedure and one-month observation period
20 | years-old | <= |
59 | years-old | >= |
Male and Female
A) Don't reach score 0 of auditory hallucination in AHRS, regardless of pharmacotherapy of antipsychotics with sufficient dose and duration.
B)"Sufficient dose" refers to more than 600mg/day chlorpromazine-equivalent dose and "sufficient duration" refers to more than 4 weeks.
1) Traumatic brain injury with loss of consciousness
2) With cripping device or electrode of deep brain stimulation
3) With embedding cochlea stimulating device
4) With cardiac pacing device
5) Epilepsy
6) Abuse or dependence of alcohol or any illegal drugs
7) Mental retardation or personality disorder
8) Cerebrovascular disease
9) Severe neurological disease
10) Under treatment of severe infection disease or malignancy
11) Pregnant woman
12) Left-handed
13) judged inappropriate to participate into the study by medical doctor
40
1st name | |
Middle name | |
Last name | Masaomi Iyo |
Graduate School of Medicine, Chiba University
Department of Psychiatry
1-8-1 Inohana, Chuo-ku, Chiba
043-222-7171
1st name | |
Middle name | |
Last name | Nobuhisa Kanahara |
Graduate School of Medicine, Chiba University
Department of Psychiatry
1-8-1 Inohana, Chuo-ku, Chiba
043-222-7171
kanahara@faculty.chiba-u.jp
Department of Psychiatry, Graduate School of Medicine, Chiba University
None
Self funding
NO
千葉大学医学部附属病院
2011 | Year | 07 | Month | 30 | Day |
Unpublished
Completed
2010 | Year | 11 | Month | 10 | Day |
2011 | Year | 07 | Month | 01 | Day |
2015 | Year | 09 | Month | 13 | Day |
2015 | Year | 09 | Month | 13 | Day |
2015 | Year | 09 | Month | 13 | Day |
2015 | Year | 09 | Month | 13 | Day |
2011 | Year | 07 | Month | 27 | Day |
2017 | Year | 12 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007159